Opportunities of combination therapy in reproductive age patients with bacterial vaginosis combined with vulvovaginal candidiasis

Opportunities of combination therapy in reproductive age patients with bacterial vaginosis combined with vulvovaginal candidiasis

Aim: to assess the effectiveness of combination therapy in reproductive age patients with mixed vaginitis.Materials and Methods. A retrospective analysis of the therapeutic effectiveness for mixed vaginitis in 158 patients aged 18 to 45 years was carried out. For treatment, the drugs Gainomax (stand...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. V. Savelieva, E. A. Bukharova, E. G. Galyanskaya, N. V. Nosova, P. V. Davydov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2025-01-01
Series:	Акушерство, гинекология и репродукция
Subjects:	mixed vaginitis reproductive age thioconazole and tinidazole
Online Access:	https://www.gynecology.su/jour/article/view/2285
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differential PCR diagnosis of bacterial vaginosis, aerobic vaginitis and vulvovaginal candidiasis
by: T. I. Makhova, et al.
Published: (2022-06-01)

Evaluation of epidemiological, clinical, and microbiological features of vulvovaginal candidiasis
by: Faraji, Reza, et al.
Published: (2025-04-01)

Identifying changes in vaginal fluid using SERS: Advancing diagnosis of vulvovaginal candidiasis
by: Sylwia M. Berus, et al.
Published: (2024-12-01)

Bacterial vaginosis - diagnostic dilemma and implications
by: Atanasievska Sonja, et al.
Published: (2023-01-01)

Vulvovaginal Candidiasis Among Women with Bacterial Vaginosis Attending Aminu Kano Teaching Hospital, Nigeria
by: Sule, H.*, Kumurya, A.S., Nasir, A.
Published: (2018-03-01)

Etiological profile and risk factors of vulvovaginitis among women of reproductive age in a tertiary care hospital in northern India
by: Agarwal S, et al.
Published: (2025-06-01)

Hallmarks of Bacterial Vaginosis
by: Diana Cristina Pérez-Ibave, et al.
Published: (2025-04-01)

New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections
by: Francesco De Seta, et al.
Published: (2025-08-01)

Prevalence of vulvovaginal candidiasis among pregnant women in Africa: A systematic review and meta-analysis
by: Ahmed Osman Mohamed, et al.
Published: (2022-08-01)

Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
by: A. B. Khuraseva, et al.
Published: (2018-11-01)

A spectrophotometrical analitic method elaboration for tinidazole’s quantity determination from tablets
by: Dragos, D.,, et al.
Published: (2008-12-01)

Comparison of bacterial vaginosis symptoms reported in social media vs. those reported by patients
by: Andriana H. Velmahos, et al.
Published: (2025-02-01)

Study on the Clinical Efficacy of Combined Therapy with Minocycline Hydrochloride Ointment and Tinidazole for Chronic Periodontitis: Retrospective Study
by: Wu Q, et al.
Published: (2025-04-01)

Correlation of Trichomonas vaginalis to bacterial vaginosis: a laboratory-based study
by: Maysaa El Sayed Zaki, et al.
Published: (2010-01-01)

Frequency of Bacterial Vaginosis among Pregnant Women Experiencing Preterm Labor
by: Y Saleh Khudhur
Published: (2024-03-01)

Risk factors for recurrence of vulvovaginal infections
by: Ekaterina V. Kolesnikova, et al.
Published: (2024-12-01)

Diagnosis of bacterial vaginosis: Comparison of Nugent´s and novel microscopic method
by: Nenadić Dane, et al.
Published: (2022-01-01)

Temporal dynamics of the vaginal microbiome and host immune markers before, during, and after metronidazole treatment for bacterial vaginosis
by: Amanda Williams, et al.
Published: (2025-07-01)

Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
by: Philipp Foessleitner, et al.
Published: (2025-01-01)

Bacterial Vaginosis and Trichomononiasis. Fundamental World Guidelines on Management and Therapy of the Patients
by: M. A. Gomberg
Published: (2020-05-01)

Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)
by: Oksana N. Volkova, et al.
Published: (2025-02-01)

Effects of intravaginal curcumin gels combined with electroporation on vulvovaginal candidiasis
by: Yizhi Zhang, et al.
Published: (2025-01-01)

A randomized controlled trial to compare antibiotic prophylaxis in elective gynecological surgeries: Single dose of cefazolin versus single dose of cefazolin and tinidazole
by: Shivani Garg, et al.
Published: (2022-01-01)

Extracellular Traps in Patients Diagnosed With Bacterial Vaginosis, Trichomoniasis, Candidiasis, Noninfectious Vaginitis and Cytolytic Vaginosis
by: María G. Ramírez-Ledesma, et al.
Published: (2024-01-01)

In Vitro Bactericidal Activity of a Neomycin-Polymyxin B-Nystatin Combination Compared to Metronidazole and Clindamycin Against the Main Bacteria Involved in Bacterial Vaginosis and Aerobic Vaginitis
by: Catherine Feuillolay, et al.
Published: (2025-02-01)

Characterization of bacterial communities of ewe’s vaginal tract and its potential impact on reproductive efficiency
by: E. L. Reinoso-Peláez, et al.
Published: (2025-05-01)

BVBlue as a diagnostic instrument for the diagnosis of bacterial vaginosis: a systematic review
by: Igor Ian Wiguna, et al.
Published: (2025-02-01)

Lean and eco-efficient method for evaluating the potency of tinidazole in tablets
by: Pollyanna Barbara Henrique, et al.
Published: (2024-12-01)

A Fungistatic Strategy Using a Shear-Thinning pH-Responsive CMCS-OHA-Lp/Lr Hydrogel for Vulvovaginal Candidiasis
by: Yuanmin Zhao, et al.
Published: (2025-04-01)

Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018
by: A. D. Makatsariya, et al.
Published: (2019-09-01)

Phenotypic characterization and antifungal susceptibility profile of Candida isolates from women with vulvovaginal candidiasis at a community health center linked to a teaching institution in the Sub-Himalayan region of North India
by: Sangeeta Rawat, et al.
Published: (2023-12-01)

Proof of concept study of a novel bioadhesive clindamycin phosphate 2% vaginal gel to treat bacterial vaginosis
by: A. Dupre, et al.
Published: (2020-08-01)

Assessment of vaginal microbiota in Brazilian women with and without bacterial vaginosis and comparison with Nugent score
by: Laura Maria Andrade Oliveira, et al.
Published: (2018-02-01)

Prevention of vaginal atrophy after treatment for tumors of the female reproductive system
by: A. G. Kedrova
Published: (2020-03-01)

Microbiological reasoning of the formation and development of vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-08-01)

The sow vaginal and gut microbiota associated with longevity and reproductive performance
by: Ziyu Liu, et al.
Published: (2025-01-01)

Characteristics of Peanut Protein-Derived Carbon Dots and Their Application in Cell Imaging and Sensing of Metronidazole
by: Junyan Liao, et al.
Published: (2025-04-01)

Green direct and ratio-based spectrophotometric manipulated methods for tinidazole and ciprofloxacin hydrochloride concomitant assay in their tablet dosage form
by: Safa M. Megahed, et al.
Published: (2025-03-01)

Risk factors for recurrent vulvovaginal candidiasis
by: Janković Slobodan, et al.
Published: (2010-01-01)

IL-17 in Protective Immunity to Vaginal Candidiasis
by: Baghdad Science Journal
Published: (2016-03-01)